[Modification of disordered coronary and peripheral circulation using essential phospholipids].
D000328:Adult; D000368:Aged; D001775:Blood Circulation / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D002784:Cholesterol / Q000097:blood; D004562:Electrocardiography; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000494:pharmacology / Q000627:therapeutic use*; D010992:Plethysmography, Impedance; D014280:Triglycerides / Q000097:blood
D010743:Phospholipids; D014280:Triglycerides; D002784:Cholesterol
Zur Beeinflussbarketi koronarer und peripherer Durchblutungsstörungen mittles "essentieller Phospholipide"